Small cell lung cancer
![Quaratusugene Ozeplasmid Plasmid Plus Atezolizumab in ES-SCLC Receives FTD from FDA | Pharmtales](https://pharmtales.com/wp-content/uploads/2023/07/Quaratusugene-Ozeplasmid-Plasmid-Plus-Atezolizumab-in-ES-SCLC-Receives-FTD-from-FDA.jpg)
Quaratusugene Ozeplasmid Plasmid Plus Atezolizumab in ES-SCLC Receives FTD from FDA
SG Tylor
Source – Genprex On June 28, 2023, Genprex has announced that the FDA has granted fast track designation (FTD) to ...
Source – Genprex On June 28, 2023, Genprex has announced that the FDA has granted fast track designation (FTD) to ...